AbbVie has announced plans to invest $380m to construct two new active pharmaceutical ingredient (API) manufacturing ...

Part of AbbVie’s vow to invest $100 billion in the U.S. over the next decade, the two Illinois facilities will make active ...

The transition to platform adoption requires platform providers to address concerns around control, lock-in and pricing.

Outsource API manufacturing to India for lower costs, GMP-compliant quality, scalable production, and faster time-to-market for pharma companies.

A developer-targeting campaign leveraged malicious Next.js repositories to trigger a covert RCE-to-C2 chain through standard ...

AbbVie is investing $380 million to build two new active pharmaceutical ingredient manufacturing facilities at its headquarters campus in North Chicago. Construction is set to begin in spring 2026, ...

Tarsus Pharmaceuticals remains a Strong Buy, driven by Xdemvy's robust growth and management's $2B+ peak sales target. Click ...

APi Gr (NYSE:APG) is preparing to release its quarterly earnings on Wednesday, 2026-02-25. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect APi Gr ...

The upgraded platform enhances batch processing, API performance, and secure cloud automation for businesses worldwide.

Apple's App Store age verification system has been updated to ensure compliance can be maintained in places like Louisiana, Utah, Australia, Brazil, and Singapore.

AbbVie invests $380 million to build two new API manufacturing facilities in North Chicago while Bora Pharmaceuticals Co., Ltd. and GSK have renewed a five-year global manufacturing partnership.